Tilly's (TLYS) Stock Price, News & Analysis

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilly's in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TLYS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TLYS, but not buy additional shares or sell existing shares.
View TLYS analyst ratings or view top-rated stocks.

3 Wall Street research analysts have issued 12-month target prices for Tilly's' shares. Their TLYS share price targets range from $7.50 to $8.25. On average, they predict the company's share price to reach $7.88 in the next twelve months. This suggests a possible upside of 27.2% from the stock's current price.
View analysts price targets for TLYS or view top-rated stocks among Wall Street analysts.

Tilly's' stock was trading at $7.54 on January 1st, 2024. Since then, TLYS stock has decreased by 17.9% and is now trading at $6.19.
View the best growth stocks for 2024 here.

Tilly's saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 495,500 shares, a decrease of 24.5% from the April 15th total of 656,200 shares. Based on an average daily trading volume, of 70,200 shares, the short-interest ratio is presently 7.1 days. Approximately 2.2% of the shares of the stock are sold short.
View Tilly's' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 6th 2024.
View our TLYS earnings forecast.

Tilly's will be holding an earnings conference call on Thursday, June 6th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "10188068".

Tilly's, Inc. (NYSE:TLYS) posted its quarterly earnings data on Thursday, March, 14th. The specialty retailer reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.05. The specialty retailer had revenue of $173.02 million for the quarter, compared to analyst estimates of $171.65 million. Tilly's had a negative net margin of 5.54% and a negative trailing twelve-month return on equity of 11.93%.

Tilly's issued an update on its first quarter 2024 earnings guidance on Thursday, March, 14th. The company provided earnings per share guidance of -0.540--0.420 for the period, compared to the consensus earnings per share estimate of -0.400. The company issued revenue guidance of $109.0 million-$119.0 million, compared to the consensus revenue estimate of $124.1 million.

97 employees have rated Tilly's Chief Executive Officer Edmond Thomas on Glassdoor.com. Edmond Thomas has an approval rating of 71% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilly's investors own include Pennsylvania Real Estate Investment Trust (PEI), ADMA Biologics (ADMA), CNBX Pharmaceuticals (CNBX), KushCo (KSHB), Organigram (OGI), Zosano Pharma (ZSAN), DHT (DHT), EnLink Midstream (ENLC) and Washington Prime Group (WPG).

Tilly's' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (4.27%), Pacific Ridge Capital Partners LLC (2.00%), First Eagle Investment Management LLC (1.43%), Empowered Funds LLC (0.38%), State Board of Administration of Florida Retirement System (0.22%) and Russell Investments Group Ltd. (0.05%). Insiders that own company stock include Bernard Zeichner, Edmond Thomas, Fund 1 Investments, Llc, Hezy Shaked, Janet Kerr, Jonathon David Kosoff, Marc Nissan, Michael Henry, Robert Simon Goodwin and Seth R Johnson.
View institutional ownership trends.

Shares of TLYS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.